2025 saw lower sales and a wider net loss due to market challenges, but strategic advances in AirCare and HealthCare, new international partnerships, and successful capital raises have positioned the company for expected sales growth and improved scalability in 2026.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.